tiprankstipranks
Trending News
More News >
Allergy Therapeutics PLC (GB:AGY)
LSE:AGY
Advertisement

Allergy Therapeutics (AGY) Revenue

Compare
16 Followers

Allergy Therapeutics Revenue

Allergy Therapeutics had a revenue of 34.03M in the quarter ending Dec 31, 2024, with 57.35%. This bring the company's revenue in the last twelve months to 55.66M, Decreased 0.83%. In the fiscal year ending Dec 31, 2023, Allergy Therapeutics had annual revenue of 55.20M with -7.36% growth.
Revenue (ttm)
55.66M
Revenue Growth
4.50%
P/S Ratio
7.34
Revenue/Employee
£90,194
Employees
612
Market Cap
£405.15M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2023
55.20M-4.39M-7.36%
Dec 31, 2022
59.59M-13.18M-18.11%
Dec 31, 2021
72.77M-11.56M-13.71%
Dec 31, 2020
84.33M6.13M+7.83%
Dec 31, 2019
78.20M4.49M+6.09%
Dec 31, 2018
73.72M5.37M+7.86%
Dec 31, 2017
68.35M4.21M+6.56%
Dec 31, 2016
64.14M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis